about
The impact of next-generation sequencing technologies on HLA researchTranslation of genomics-guided RNA-based personalised cancer vaccines: towards the bedsideA population response analysis approach to assign class II HLA-epitope restrictionsThe relevance of HLA sequencing in population genetics studiesImmunoNodes - graphical development of complex immunoinformatics workflowsHLA typing from RNA-seq data using hierarchical read weighting [corrected].OptiType: precision HLA typing from next-generation sequencing data.HLA-VBSeq: accurate HLA typing at full resolution from whole-genome sequencing data.Mapping Bias Overestimates Reference Allele Frequencies at the HLA Genes in the 1000 Genomes Project Phase I Data.Evaluation of computational programs to predict HLA genotypes from genomic sequencing data.Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.Inference of high resolution HLA types using genome-wide RNA or DNA sequencing readsPSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinitySequence-Based Genotyping of Expressed Swine Leukocyte Antigen Class I Alleles by Next-Generation Sequencing Reveal Novel Swine Leukocyte Antigen Class I Haplotypes and Alleles in Belgian, Danish, and Kenyan Fattening Pigs and Göttingen Minipigs.Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.HLAreporter: a tool for HLA typing from next generation sequencing dataA catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell linesComplete haplotype phasing of the MHC and KIR loci with targeted HaploSeq.FRED 2: an immunoinformatics framework for Python.A novel RNAseq-assisted method for MHC class I genotyping in a non-model species applied to a lethal vaccination-induced alloimmune diseaseTCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expressionImmunoinformatics and epitope prediction in the age of genomic medicine.Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.Bioinformatics for cancer immunotherapy target discovery.A genomic perspective on HLA evolution.Computational genomics tools for dissecting tumour-immune cell interactions.Immunoregulatory functions of VISTA.Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors.Profiling tissue-resident T cell repertoires by RNA sequencing.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues.HLA genotyping by next-generation sequencing of complementary DNA.Informatics for cancer immunotherapy.MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial.Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.
P2860
Q26796663-EF8749E9-9151-404F-A325-9E7DE9892FF4Q27015695-98A31E61-B5CB-48C3-910A-08966A29878FQ28395866-6F7F8065-35EF-4CF1-A174-2BA63D69C6EDQ28654923-D537982E-B6D6-41F6-B68F-7F5A9BF25524Q30250980-39470C54-0861-4559-9D5D-FB60ED46302CQ30654393-5E723AAB-A907-497C-8CF7-65E279E1FABFQ30843963-FD297876-1720-42AD-AC12-8350F252961AQ30898594-4C7F82A0-5BB8-4F1F-888D-369D68A01F5AQ30912274-D1D74361-36B6-4EC1-89FE-CF3E9E35BF6DQ31140417-ECC1CB62-6B5F-4F71-8002-41BE29E362F7Q33556731-38D30F6F-F7A3-4B9F-A6CB-4B2776437017Q33669140-8B44DFD8-4A1C-434A-9A16-02965B272E30Q33785947-B43F8D5F-69AC-4471-AACB-7DB4611B92F7Q33804315-6FF11E1B-D8C7-410F-9378-071DC2D5D377Q34579653-CF05F575-D7D5-45BE-8027-A96FE09BCC1DQ35613399-25BDF024-2F4F-4CA0-B44E-90CCC30096B6Q35626593-89C0FEE4-4389-4C4F-9C5A-FAB6A6ED18C7Q35833809-01CD6FBF-D55A-4317-93BC-BD835E0F3B0BQ36011145-1DE6469C-63E5-4CD1-B2D8-A792BAAB8AEFQ36020341-2CE57C6F-176F-469D-AA12-474A6A4E5938Q36301828-181D332F-C135-4A5A-8E71-0244687EDAC2Q36304147-F53C7807-698A-4859-9E17-2F809EA88992Q36563549-8CDFF724-1A0F-4DA4-B117-A5890ED4D6A7Q37006391-4A6BF3BD-3F61-4466-9622-6B8E239BE550Q37080412-C897D9D6-5442-4CF6-8FBC-F35DDA9D3A61Q38262688-EC6F37C1-6A8E-4BEB-8226-EBF6DC3668ACQ38688783-B74FA05D-F50B-4312-8523-EECF117F135EQ38885361-5B67A9A1-568B-445A-A104-95E46284BEE1Q38930123-A1966182-D884-4EF7-8DA2-D6B3DCFB44E5Q39157730-7E87CACF-DD06-4F25-88FB-A6313EAA5B7EQ40259752-0991DFF5-D5D5-4F5A-BC1C-C3BF384A8D40Q41514095-00B777EB-EA83-4CE7-AEB3-0BBA0EB7D162Q42586718-CFC9EF4B-DA0D-4AC2-86E1-508BC9A464DEQ47136511-E6A75145-7D87-4503-A44E-7FA5B593F1A4Q47148549-76516FA2-1CD3-45BE-857D-5695AC5110E5Q47290509-0E4B0271-C296-4AF6-ADC8-83D599FC2402Q47560871-C17B0B04-74A6-494A-B186-C9DCBFE0434AQ48192591-3F8A80FB-42EA-4843-B075-DE00C007A31CQ49237244-32C18047-E3CA-4E40-9451-3D75541899C8Q49483662-5F58A51C-4AEE-4F8F-9788-ECA83F5FACE0
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HLA typing from RNA-Seq sequence reads
@ast
HLA typing from RNA-Seq sequence reads
@en
type
label
HLA typing from RNA-Seq sequence reads
@ast
HLA typing from RNA-Seq sequence reads
@en
prefLabel
HLA typing from RNA-Seq sequence reads
@ast
HLA typing from RNA-Seq sequence reads
@en
P2093
P2860
P50
P356
P1433
P1476
HLA typing from RNA-Seq sequence reads
@en
P2093
John C Castle
Jos de Graaf
Martin Löwer
Michael Schäfer
Mustafa Diken
Ozlem Türeci
Valesca Boisguérin
P2860
P2888
P356
10.1186/GM403
P577
2012-12-22T00:00:00Z
P5875
P6179
1001740769